AQST: Aquestive Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 353.06
Enterprise Value ($M) 356.72
Book Value ($M) -106.49
Book Value / Share -1.18
Price / Book -3.32
NCAV ($M) -122.94
NCAV / Share -1.36
Price / NCAV -2.87

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.13
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.87
Current Ratio 2.24

Balance Sheet (mrq) ($M)
Current Assets 40.97
Assets 57.42
Liabilities 163.91
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 50.58
Operating Income -15.10
Net Income -7.87
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -6.38
Cash from Investing -0.99
Cash from Financing 3.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-01 13G Venrock Healthcare Capital Partners III, L.P. 6.50
02-14 13G Armistice Capital, Llc 5.88

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 576,821 1,835,575 31.42
2024-04-24 597,408 1,979,259 30.18
2024-04-23 483,512 1,596,427 30.29
2024-04-22 597,324 423,677 140.99

(click for more detail)

Similar Companies
ANIP – ANI Pharmaceuticals, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc. ARCT – Arcturus Therapeutics Holdings Inc.
ARDX – Ardelyx, Inc.


Financial data and stock pages provided by
Fintel.io